Latest "Biomarker discovery Driving technologies" News Stories

Sapio announces availability of Exemplar Biomarker Discovery LIMS

Sapio Sciences is pleased to announce the immediate availability of Exemplar Biomarker Discovery LIMS.

Biomarker Development Timeline

The process of biomarker discovery through widespread clinical use is a long road

GVB BIO licenses biomarker database to FDA

GVK Biosciences, a discovery, research and development organization providing a broad spectrum of services, is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the FDA. The GOBIOM database, which has...

KineMed, GSK enter multi-year biomarker discovery partnership

KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.

UMDNJ-School of Osteopathic Medicine establishes Biomarker Discovery Center

Following recent discoveries by its researchers that could significantly change the diagnosis and treatment of a number of diseases, the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine has established the Bio...

Adaptive signs biomarker discovery partnership in oncology with Bristol-Myers

Adaptive Biotechnologies has signed immunological biomarker discovery partnership with Bristol-Myers Squibb in the field of oncology.

Driving down the cost of drug discovery

David Leahy shares his thoughts on driving down drug discovery costs and how this will, in time, allow for better development of personalised medicine. While the pharma industry may believe drug discovery has been fully optimized, David Leahy disagr...

From drug discovery to biomarker-driven clinical trials in lymphoma

Improvements in the pathological classification of lymphoma have had little impact on advancing drug development or improving the cure rate. The authors discuss the current status of biomarker development in lymphoma, and how novel biomarker-directed...

Biomarker predicts response to cancer treatment

(VIB (the Flanders Institute for Biotechnology)) VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab. If validated, t...

Compugen, Merck Serono form Israeli biomarker JV

Compugen Ltd. (NASDAQ:CGEN) and Merck Serono S.A. launched Neviah Genomics Ltd., an Israeli JV focused on developing biomarker tests to predict drug-induced toxicity. Merck Serono Ventures will provide initial funding for the JV, which will be based...

Gachon University acquires access to Agilent proteomics and glycoproteomics technologies for biomarker discovery

Agilent Technologies Inc and Gachon University of Medicine and Science, based in Korea, have formed a collaboration in biomarker discovery using proteomics and glycoproteomics. The College of Pharmacy at Gachon University is world-renowned for its re...

Gentris, China’s SIPM Collaborate on Biomarker Discovery

Fast Forward, Ezose Partner on MS Biomarker Discovery

Plexpress, Phalanx Offer Biomarker Discovery and Validation Service

Biomarker Of Tamoxifen Resistance In Breast Cancer Identified

New research led by the University of Manchester in the UK has found a biomarker or molecular "flag" in women with breast cancer who do not repond, or who have become resistant, to treatment with the hormone drug tamoxifen. The researchers say thei...

Adaptive, BMS ink biomarker discovery collaboration agreement

Adaptive Biotechnologies, a Seattle-based developer of next generation sequencing assays, has entered into a collaboration agreement with Bristol-Myers Squibb for the discovery of immunological biomarkers in oncology.

New biomarker for bone marrow cancer: Discovery suggests new ways of treating multiple myeloma

Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not get cured with current sta...

Teen Drink Driving Reduced By Graduated Driving Laws

State laws that limit driving privileges for teens have reduced the incidence of drinking and driving among the nation's youngest licensees, according to a new study from researchers at Washington University School of Medicine in St. Louis. The vast...

Discovery Of A Potential Biomarker For Pregnancy-Related Heart Disease

Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history of heart disease and the ca...

Discovery Of Gene Linked To Age-Related Hearing Loss

University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality...

Adaptive Bio, BMS In Biomarker Discovery Pact

Will use immune assay to identify biomarkers in cells of cancer patients

Unlocking Protein Biomarker Discovery for Pharma, Biotech and Academia

Xtalks presents a live webinar on August 23, 2012 at 11:00am EDT on protein biomarker discovery. Dr. Steve Williams, Chief Medical Officer, SomaLogic, and Dr. Nick Saccomano, Chief Technology Officer, SomaLogic, will discuss a transformative proteomic biomarker discovery technology developed by SomaLogic that measures over 1129 human proteins in small sample volumes (50 µL) with a sensitive,...

Graduated driving laws reduce teen drunk driving

(Washington University School of Medicine) State laws that limit driving privileges for teens have reduced the incidence of drinking and driving among the nation's youngest licensees, according to a new study from researchers at Washington University...

Merck Serono spin-off Quartz Bio to offer biomarker data analysis

Merck Serono, a division of Merck, has created Quartz Bio, the second spin-off company resulting from its Entrepreneur Partnership Program launched in April. Quartz Bio will offer biomarker data management and exploratory biomarker analysis services...

Merck Serono, Compugen establish new biomarker company Neviah Genomics

Merck Serono of Darmstadt, Germany, and Compugen, a therapeutic product discovery company of Tel Aviv, Israel, have established a novel start-up company called Neviah Genomics, focused on the discovery and development of novel biomarkers for the pred...